171 related articles for article (PubMed ID: 1077788)
1. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
Beckerhoff R; Uhlschmid G; Vetter W; Armbruster H; Nussberger J; Reck G; Schmied U; Siegenthaler W
Clin Sci Mol Med Suppl; 1975 Jun; 2():41s-44s. PubMed ID: 1077788
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog.
Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W
Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555
[TBL] [Abstract][Full Text] [Related]
3. Studies on the effect of angiotensin II and of Des -angiotensin II on blood pressure, plasma renin activity and plasma aldosterone in the dog.
Beckerhoff R; Uhlschmid G; Vetter W; Siegenthaler W
Clin Sci Mol Med Suppl; 1976 Dec; 3():147s-150s. PubMed ID: 1071593
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
Bravo EL; Khosla MC; Bumpus FM
Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
[TBL] [Abstract][Full Text] [Related]
5. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
6. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
[TBL] [Abstract][Full Text] [Related]
7. [Effects of an analogue of angiotensin II, [Sar1,Ile8] ATII, on blood pressure, plasma renin activity and plasma aldosterone in various forms of hypertension].
Yamamoto I; Kim KS; Miyamori I; Morimoto S; Takeda R
Nihon Naibunpi Gakkai Zasshi; 1977 Jul; 53(7):910-20. PubMed ID: 913717
[No Abstract] [Full Text] [Related]
8. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.
Hata T; Ogihara T; Nakamaru M; Gotoh S; Masuo K; Saeki S; Kumagai A; Kumahara Y
Eur J Clin Pharmacol; 1982; 23(1):7-10. PubMed ID: 6751836
[TBL] [Abstract][Full Text] [Related]
9. The effect of angiotensin II antagonist, Sar1-Ile8-angiotensin II, on furosemide-induced increase in plasma noradrenaline, renin activity and aldosterone in unanesthetized dogs.
Ueno Y; Arita M; Suruda H; Ohtani H; Minakata T; Kuchii M; Nishio I; Masuyama Y
Jpn Circ J; 1980 Dec; 44(12):981-7. PubMed ID: 7003179
[TBL] [Abstract][Full Text] [Related]
10. Agonistic activities of isoleucine8-angiotensin II in man.
Kono T; Taniguchi A; Imura H; Oseko F; Khosla MC
Endocrinol Jpn; 1985 Oct; 32(5):701-8. PubMed ID: 3912161
[TBL] [Abstract][Full Text] [Related]
11. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and not sodium status is the major determinant of the agonistic/antagonistic balance of saralasin's actions.
Fagard R; Amery A; Lijnen P
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():75s-78s. PubMed ID: 7004740
[TBL] [Abstract][Full Text] [Related]
13. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
14. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
15. The effects of angiotensin II blockade in conscious sodium-depleted dogs.
Stephens GA; Davis JO; Freeman RH; Watkins BE; Khosla MC
Endocrinology; 1977 Aug; 101(2):378-8. PubMed ID: 885110
[No Abstract] [Full Text] [Related]
16. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
17. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
18. Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
Saito I; Saruta T; Eguchi T; Nakamura R; Kondo K; Iyori S; Kato E
Jpn Heart J; 1978 Sep; 19(5):741-7. PubMed ID: 731936
[TBL] [Abstract][Full Text] [Related]
19. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion.
Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
Prog Biochem Pharmacol; 1976; 12():53-62. PubMed ID: 1019170
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
